Document:

EXHIBIT 10.2

[LOGO GETZLER HENRICH MANAGEMENT & FINANCIAL CONSULTANTS]

March 30, 2009

Mr. Louis V. Aronson
President and Chief Executive Officer
Ronson Corporation
Corporate Park III, Campus Drive
Somerset, NJ 08875

Dear Mr. Aronson:

Reference  is  made  to  the  Engagement  Letter  dated  January  6,  2009  (the
"Engagement   Letter")  between  Getzler  Henrich  &  Associates  LLC  ("Getzler
Henrich")  and  Ronson   Corporation   (together  with  its  subsidiaries,   the
"Company").  Capitalized  terms utilized herein and not otherwise defined herein
shall have the meanings set forth in the Engagement Letter.

Getzler  Henrich and the Company have agreed to expand the scope of the services
provided by Getzler Henrich under the Engagement  Letter,  and are entering into
this new agreement (this  "Agreement") to define the scope of the services to be
provided  by  Getzler  Henrich  and the fees to be paid  with  respect  thereto.
Accordingly,  Getzler Henrich shall provide,  and the Company shall retain,  the
services  of  Joel  Getzler  as  Chief   Restructuring   Officer   ("CRO")  with
responsibility for operations,  finance,  accounting and related  administrative
issues, subject to the terms hereof and to the authority of and reporting to the
Board of Directors of the Company (the "Board"). The CRO shall be authorized but
not  required to make final and binding  decisions  with  respect to  operating,
finance and accounting matters in as he deems necessary or appropriate.  The CRO
shall devote such time to the performance of his services  hereunder,  including
onsite involvement at the Company's offices, as he determines appropriate in his
sole  discretion.  The CRO is  authorized  to  utilize  the  services  of  other
personnel of Getzler  Henrich in performing  the services  hereunder,  and it is
understood  and agreed that  Robert  Gorin will have a  substantial  role in the
performance of the services hereunder.

In particular, but subject to the foregoing, the CRO shall:

         o        Manage the day-to-day operations of the Company;

         o        Supervise  the  banking  relationships,  cash  management  and
                  budgeting process of the Company;

         o        Supervise the management and employees of the Company;

         o        Monitor, and work to facilitate,  the sale of Ronson Aviation,
                  Inc.  ("RAI") and any other  Transaction  (as  defined  below)
                  including, but not limited to, the engagement of an investment
                  banker   satisfactory   to  CRO  and  Wells   Fargo   National
                  Association,  acting through its Wells Fargo  Business  Credit
                  operating division ("WF");

         o        Render  advice to the Board with  respect  to, but not limited
                  to:

<PAGE>

                  o        The  borrowing  of money and creation of liens on the
                           assets of the Company;

                  o        The sale of all or part of the assets of the Company;

                  o        The termination of the Company's operations,  and the
                           liquidation,  surrender  and/or  abandonment  of  the
                           Company's assets;

                  o        Any   proceedings  on  behalf  of  or  involving  the
                           Company, including, without limitation, assigning the
                           Company's  assets for the benefit of its creditors or
                           filing  for  bankruptcy  or  other   protection  from
                           creditors  in state  or  federal  courts  (any of the
                           foregoing, an "Insolvency Proceeding"); and

                  o        The  development  of  restructuring   plans  for  the
                           Company, including, without limitation, restructuring
                           plans involving the Company's  existing secured debt,
                           a  recapitalization  of the Company,  or asset sales,
                           divestitures,  liquidations  or other  disposition of
                           assets of the Company,  whether as part of or outside
                           of any Insolvency  Proceeding  (any of the foregoing,
                           including   without   limitation   a  sale  or  other
                           disposition  in whole or in part of RAI or the assets
                           thereof, a "Transaction").

Getzler Henrich and the Company agree that:

         o        Getzler   Henrich   and  the  CRO   shall,   subject   to  the
                  Confidentiality  Agreement, have open and unfettered access to
                  all information concerning but not limited to:

                  o        The sale of RAI and any other potential Transaction;

                  o        Efforts to obtain financing for the Company; and

                  o        Any and all data relating to the Company.

         o        It is  expressly  agreed that any member of the Board,  or the
                  existing CEO of the Company,  having a request for an employee
                  of the Company will make such request through the CRO.

         o        The  CRO  will   report  to  John  Bess  and  Gerard   Quinnan
                  (collectively,  the "Report Person"), it being agreed that the
                  CRO can report to, and receive  approval  from,  either Report
                  Person.

         o        Louis V. Aronson II, will have the following  responsibilities
                  during the term of this Agreement: advise and consult with the
                  CRO from time to time at the reasonable request of the CRO, in
                  all  matters  relating  to the  business  and  affairs  of the
                  Company.  During the term of this Agreement,  Mr. Aronson will
                  only be physically  present at the  Company's  premises at the
                  discretion of the CRO.

         o        Payment  of all  salaries,  fees,  perks and  expenses  to all
                  members of the Board and the CEO are deferred  during the term
                  of this  Agreement  until  the CRO  deems  it  appropriate  to
                  reinstate  them (the  foregoing  not to  extend to any  health
                  insurance

                                       2
<PAGE>

                  premiums  paid for any of such persons in a manner  consistent
                  with the Company's past practices);  provided, that no amounts
                  so deferred  shall be paid unless the Deferred  Amount and the
                  Existing Receivable have been paid in full.

         o        The go-forward  salaries of D. Holcomb, W. Blair, A. Grabicki,
                  S. Smith,  and B.  Clemmens  will be returned to the  salaries
                  being earned prior to December 16, 2008.

         o        The CRO can engage other third party professionals in order to
                  advise him and the Company, including, but not limited to, the
                  engagement of an investment banker satisfactory to CRO and WF.

The CRO shall report  regularly to the Report  Person and shall seek approval of
the Board for any  Transactions  of a type  typically  requiring  such approval.
Without limiting the foregoing,  the CRO shall not be authorized to terminate or
hire any officer of the Company  without  prior  written  approval of the Report
Person.

The CRO shall further,  from time to time at the direction of the Report Person,
advise the Report Person with respect to the ongoing activities of the Company's
consumer products division.

Getzler  Henrich  shall be  compensated  during  the term of this  Agreement  as
follows:

         1.       A flat  fee of  $15,000  per  week  for the  services  of Joel
                  Getzler as CRO;

         2.       Hourly  charges of $475 for the services of Robert  Gorin,  as
                  needed;

         3.       Hourly charge of $335 for Hadar Weiss, as needed; and

         4.       Other  charges as set forth  below for other  Getzler  Henrich
                  staff.

All work performed  (other than Joel Getzler) will be billed on an hourly basis.
The hourly  rates  (other than with  respect to rates for Joel  Getzler,  Robert
Gorin and Hadar Weiss) are as follows:

         Principal / Managing Director               $405-550

         Vice President / Director                   $335-485

         Associate Professionals and Consultants     $190-375

Note that Getzler  Henrich does not provide  assurance  regarding the outcome of
its work and its fees will not be contingent on the results of such work.

Getzler   Henrich  will  bill  the  Company   weekly  for  fees  and  reasonable
out-of-pocket  expenses  incurred  by  Getzler  Henrich in  connection  with the
services  rendered  herein.  Such  expenses  include,  but are not  limited  to,
out-of-town travel (meals,  lodging,  parking,  etc.),  telephone calls, general
office services, delivery services, and photocopying. All out-of-pocket expenses
in  excess  of One  Thousand  Dollars  ($1,000)  per week are  subject  to prior
approval by the Report Person.  The Company  acknowledges  that Getzler  Henrich
invoices are due and payable each week upon  presentation.  If an invoice is not
paid in accordance  with this Agreement on a timely basis,  Getzler  Henrich and
the CRO reserve the right to cease work until the matter is settled.

                                       3
<PAGE>

Fees in the aggregate to Getzler Henrich under items 1 through 4 above shall not
exceed  $130,000 for the initial  four-week term of this  Agreement  without the
prior written approval of the Report Person.

In addition,  Getzler  Henrich shall receive a signing bonus for agreeing to act
as CRO in the amount of $200,000  (the "Signing  Bonus").  This Signing Bonus is
deemed earned in full upon execution and delivery  hereof,  and shall be payable
as provided below.

The Company acknowledges that it owes Getzler Henrich $190,000 in fees under the
Engagement Agreement for services rendered prior to the date hereof and for fees
and expenses in connection  with creating and perfecting  the security  interest
referred  to below  (the  "Existing  Receivable"),  which  shall be  payable  as
provided below. The Company acknowledges and agrees that the Existing Receivable
is payable without offset or counterclaim, and the Company agrees that it has no
claim against  Getzler  Henrich or any of its  personnel  for services  rendered
under the Engagement  Letter and releases  Getzler  Henrich and all such persons
from any liability with respect thereto.

During the term of this  Agreement,  Getzler Henrich shall receive $10,000 (plus
any and all expenses  payable as provided above) on a weekly basis.  The balance
of the amounts payable under this Agreement,  including, without limitation, the
Signing Bonus (such amounts,  the "Deferred Amount") and the Existing Receivable
will be payable in full upon the first to occur (the "Deferred Payment Date") of
(i)  the  consummation  of a  Transaction;  provided,  that  if  both  (x)  such
Transaction  has not resulted in proceeds  sufficient  to satisfy the  Company's
indebtedness  to WF and (y) the Company is not paying  balances due to any other
professionals,  the Deferred Amount and the Existing Receivable will not be paid
upon consummation of a Transaction unless such payment is consented to by WF, or
(ii) August 31, 2009.

The  payment of the  Deferred  Amount  and the  Existing  Receivable  shall be a
condition to the consummation of any such Transaction, and Getzler Henrich shall
have the  right to inform  the other  party(ies)  to any such  Transaction  that
payment of the Deferred Amount and the Existing Receivable is a condition to the
consummation of a Transaction;  provided, that except as otherwise agreed by the
Company, Getzler Henrich and WF, if the Company and WF consent to a Transaction,
the  failure to fully pay the  amounts  set forth  above shall not result in the
Company not being able to consummate such Transaction.

The term of Getzler Henrich's  engagement hereunder shall commence when (i) this
letter is signed and delivered by the parties hereto and (ii) Getzler  Henrich's
personnel are added to the Company's Directors & Officers insurance policy ("D&O
Policy") as required  below  pursuant to an  endorsement  in form and  substance
acceptable to Getzler  Henrich.  The initial term of the  engagement  under this
Agreement  is four  (4)  weeks,  or such  longer  period  during  which WF shall
continue  to make  revolving  advances  under its credit  arrangements  with the
Company in an amount sufficient to fund the Company's cash flow needs (including
payments  required under this Agreement) (but no later than the Deferred Payment
Date),  unless sooner  terminated by either party thereto as provided below, and
shall automatically terminate at such time without notice or action by any party
unless extended in a writing signed by the parties  hereto.  This engagement may
be terminated by the Board,  at any time,  upon  providing two (2) business days
written notice thereof to Getzler  Henrich.  This Agreement may be terminated by
Getzler  Henrich (w) if its  invoices are not paid when  rendered in  accordance
with the terms of this  Agreement,  upon two (2)  business  days  prior  written

                                       4
<PAGE>

notice to the Board and failure of the Company to pay such  invoice  within such
period;  (x) any  other  material  breach  hereof by the  Company,  upon two (2)
business days prior written  notice to the Board and failure to cure such breach
within such period,  (y) Getzler  Henrich or the CRO shall not be receiving  the
cooperation  of the  Company and its  personnel  (including  the Report  Person)
necessary,  in the  judgment of Getzler  Henrich  and the CRO, to perform  their
duties  hereunder,  upon two (2) business days prior written notice to the Board
and failure to cure such lack of cooperation within such period or (z) if either
(I) a definitive  agreement  with respect to the sale of RAI has not been signed
by April  30,  2009,  or (II) if in the  judgment  of the CRO  such  sale is not
anticipated  to be  consummated  on or before  June 30, 2009 (or, if the SEC has
indicated it will review the Company's proxy statement in connection  therewith,
August 31, 2009).  This  Agreement,  and the services of Getzler Henrich and the
CRO,  shall be terminated  without  notice or action by any party if at any time
Getzler Henrich's personnel cease to be covered under the D&O Policy as required
hereunder,  or such D&O  Policy is  terminated  or the  coverage  thereunder  is
reduced or limited. In addition, Getzler Henrich can terminate this Agreement at
any time upon two (2) days  notice to the  Company  for any reason not set forth
above, provided, that in such case the Signing Bonus, if not yet paid, shall not
thereafter be payable to Getzler Henrich. No termination of this Agreement shall
affect the Company's  obligation to pay Getzler Henrich any and all accrued fees
and expenses through the date of termination,  including without  limitation the
Deferred Amount and the Existing Receivable.  Upon termination of this Agreement
(whether at the end of the foregoing  period or  otherwise),  this Agreement and
the Engagement Letter shall automatically terminate (except for those provisions
which survive such termination,  including without limitation the provisions for
payment of accrued fees and expenses and the  indemnification,  exculpation  and
insurance provisions thereof).

Concurrently  with the  execution of this letter,  the Company is adding the CRO
and Robert Gorin and Hadar Weiss,  and will  subsequently add such other persons
performing  services  hereunder as may be requested by Getzler Henrich  (Getzler
Henrich and each such person, a "Covered Person") to its existing D&O policy and
will  notify  its  insurance  carrier  for such  policy  to send  copies  of all
documentation  and other  communications  regarding  the  Company's  D&O policy,
including  without  limitation  any  renewal  or  cancellation  thereof,  to the
attention of Getzler  Henrich.  Upon any  cancellation  or nonrenewal of the D&O
policy, the Company shall exercise its rights (and hereby irrevocably authorizes
Getzler  Henrich to exercise such right on the  Company's  behalf) to extend the
claim period for a one-year  "discovery  period" and the Company  shall pay such
premiums  required  thereunder.  Neither  Getzler  Henrich nor any other Covered
Person  shall  have  any  liability  to the  Company  or  any  of the  officers,
directors,  shareholders,  employees or agents of the Company or any other party
to whom Getzler Henrich or any Covered Person might be liable in connection with
the Company or services under this Agreement or the Engagement Letter except for
liability  finally  determined by a court to have resulted from gross negligence
or willful misconduct of Getzler Henrich or any such Covered Person.

The Company hereby agrees that each Covered Person shall be a Corporate Agent of
the Company for  purposes of the  indemnification  provisions  of the  Company's
Certificate  of  Incorporation  and  By-laws  and as such shall be  entitled  to
indemnification  under such provisions,  such  indemnification to be in addition
to,  and not in lieu of,  the  indemnification  provided  for in the  Engagement
Letter and the D&O Policy  coverage.  In addition,  the Company  agrees that if,

                                       5
<PAGE>

during or following  the  completion of the service of any Covered  Person,  the
Company  modifies its By-laws or  Certificate  of  Incorporation  or  institutes
additional or alternative  arrangements with respect to the rights of directors,
officers or Corporate Agents regarding indemnification, including as a result of
changes in applicable law (i) that are less favorable than those in existence on
the date  hereof,  each  Covered  Person  shall be  entitled  to the  protection
afforded by the By-laws and/or  Certificate of Incorporation as in effect before
such  modification or  arrangements,  or (ii) that are more favorable than those
afforded by the Certificate of  Incorporation  or By-laws as of the date hereof,
proper  provision shall be made so that each Covered Person shall be entitled to
such more favorable terms (and such more favorable terms are,  without action on
the part of any party, deemed applicable to each Covered Person.

Each   Covered   Person  is  an  express   third   party   beneficiary   of  the
indemnification,  insurance and exculpation provisions of this Agreement and the
Engagement Letter.

The  indemnification  sections  of  the  Engagement  Letter  (including  without
limitation those dealing with appearance at legal  proceedings) are incorporated
by  reference  herein  as if set  forth  in full  herein.  In the  event  of any
inconsistencies  between this  Agreement and the Engagement  Letter  (including,
without limitation,  services to be performed hereunder, the fee and termination
provisions and the insurance,  indemnification and exculpation provisions),  the
provisions hereof shall govern and supersede the Engagement Letter.

Each of Ronson Consumer Products Corporation,  a New Jersey corporation ("RCPC")
and Ronson Aviation,  Inc., a New Jersey corporation  ("RAI") is benefiting from
the services provided by Getzler Henrich and the CRO hereunder. Each of RCPC and
RAI shall be jointly  and  severally  liable  with  Ronson  Corporation  for the
payment  of  all  amounts  due  Getzler  Henrich  hereunder,  including  without
limitation the payment of the Deferred Amount and the Existing Receivable.

To secure payment of all  obligations to Getzler  Henrich  hereunder,  including
without limitation the Deferred Amount and the Existing Receivable,  each of the
undersigned  grants  Getzler  Henrich a security  interest in the same assets in
which it has granted a security interest to WF (other than RAI's Lease in Mercer
County,  New Jersey),  such security interest to be subordinated to the security
interest granted to WF pursuant to an intercreditor agreement to be entered into
with WF and the  undersigned.  The  Company  will not be  required to obtain the
consent  of any  third  party  in  connection  with the  grant of such  security
interest.   The  parties  agree  to  enter  into  security   agreements  and  an
intercreditor   agreement  to  further  document  such  security   interest  and
subordination on or before April 3, 2009;  provided,  that until such agreements
are executed and delivered this  Agreement  shall suffice to effect the grant of
such  security  interest  and the  subordination  thereof  to WF.  The  proceeds
realized  from such  security  interest  shall first be applied to the  Deferred
Amount,  and then to the  Existing  Receivable.  In  addition,  if  requested by
Getzler Henrich, the Company and its Canadian subsidiary will, in agreement with
Getzler  Henrich,  allocate  the  benefits  under  this  Agreement  between  the
undersigned  and  such  Canadian  subsidiary,  and  provide  for  such  Canadian
subsidiary  to be liable  for a  commensurate  portion  of the  amounts  payable
hereunder,  such  liability  to be secured by the same  assets of such  Canadian
subsidiary  in which WF has a security  interest;  provided,  that this will not
reduce the liability of the undersigned hereunder.

                                       6
<PAGE>

If the foregoing is  acceptable to you,  please so indicate by signing below and
returning one copy of this letter.

                                         Very truly yours,

                                         GETZLER HENRICH & ASSOCIATES LLC

                                         By: s/JOEL GETZLER
                                             -----------------------------------
                                             Joel Getzler
                                             Vice Chairman

      Agreed to and accepted:

----------------------------------------
RONSON CORPORATION

By:   s/LOUIS V. ARONSON II
      ----------------------------------
      Name: Louis V. Aronson II
      Title: President
----------------------------------------
RONSON CONSUMER PRODUCTS CORPORATION

By:   s/LOUIS V. ARONSON II
      ----------------------------------
      Name: Louis V. Aronson II
      Title: President
----------------------------------------
RONSON AVIATION, INC.

By:   s/LOUIS V. ARONSON II
      ----------------------------------
      Name: Louis V. Aronson II
      Title: President
----------------------------------------
RONSON CORPORATION OF CANADA LTD.

By:   s/LOUIS V. ARONSON II
      ----------------------------------
Name: Louis V. Aronson II
Title: President
----------------------------------------

                                       7
<PAGE>

[LOGO GETZLER HENRICH MANAGEMENT & FINANCIAL CONSULTANTS]

January 6, 2009

Mr. Darryl K. Holcomb
Vice President, Chief Financial Officer
Ronson Corporation
Corporate Park III, Campus Drive
Somerset, NJ 08875

Dear Mr. Holcomb:

I enjoyed our brief discussion  yesterday.  As requested,  below is our proposal
for Ronson Corporation ("RC"). We welcome the opportunity to work with you.

We  believe  it is  important  for you to have  confidence  in our  firm and the
ability of our  professionals to deliver the services you require.  Accordingly,
this proposal has been structured to explain our  qualifications  and resources,
followed by the terms of our agreement.

OUR FIRM

Getzler Henrich & Associates LLC ("Getzler  Henrich") was founded in 1968 by our
Chairman,  Abe Getzler.  We are one of the nation's oldest corporate  turnaround
and restructuring firms, having successfully  restructured hundreds of companies
throughout  the U.S.,  Latin  America and Asia.  In addition to our  operational
restructuring focus, we have in-depth financial  restructuring,  lender/creditor
relationship management and financing experience.  Engagements have spanned more
than fifty  industries,  in diverse product areas.  Our extensive  experience in
advising middle market companies enables us to adapt our approach to the precise
needs of each individual client and make practical proposals to address issues.

OUR PEOPLE

Assignments are always managed with a proactive,  results-oriented  approach. We
believe  that in order to provide  valuable  guidance and advice to our clients,
our staff must have  first-hand  experience  at running a  business.  Therefore,
prior to joining the firm,  each team leader at Getzler  Henrich gained valuable
experience in managing companies. Experiences range from top executive positions
at middle market companies to senior management  positions at major divisions of
multinationals.

The management team for this project will include:

Joel Getzler

Joel joined Getzler  Henrich & Associates in 1990.  Prior to joining the firm he
was with Midland  Montagu  Ventures as part of a two-person  team that  invested
more than $250 million in middle market manufacturing and media companies over a
four year time span.

<PAGE>

Joel served on the boards of several companies,  advising the firms on strategic
financial and operational issues. At Getzler Henrich, Joel has served as interim
chief executive for several clients and his areas of expertise include corporate
M&A, financing, and deal negotiation. He has a B.A. from Queens College.

Robert Gorin

Robert Gorin, as Senior  Director,  brings 20 years of  client-centric  focus to
business  strategy and  operations  through his work in  corporate  turnarounds,
process  design  and  improvement,   corporate  mergers  and  acquisitions,  and
management  consulting.  Prior to joining  Getzler  Henrich,  as  President  and
General Manager of Camlog  Biotechnologies,  a dental industry supplier,  Robert
established a U.S. presence and led an aggressive  international  growth program
by re-aligning  distribution  channels and organizational  design to achieve 30%
annual  growth.  Robert was also President and Chief  Operating  Officer of EGC,
Inc., a consumer  goods  wholesaler,  distributor  and importer.  Earlier in his
career, Robert served in multiple leadership roles with Chase Manhattan Bank and
held senior roles with two major  consulting  firms,  ensuring  that his clients
developed  effective  strategies  and reaped  value  from  their  infrastructure
investments.  Robert  holds both  undergraduate  and  graduate  degrees from The
Wharton School.

Mark Samson

Mark Samson, Managing Director, is a more than 25-year veteran working with U.S.
and  foreign  retail,  distribution  and  manufacturing  companies.   Leveraging
expertise in both crisis management and operations for healthy  companies,  Mark
led  the  successful   turnaround  of  a  New  York  retail  chain,   founded  a
vertically-integrated   specialty  retailer  that  became  the  largest  in  the
industry,  and currently  serves on an ASE public  company  board.  From 1984 to
2000, Mark served as Executive  Chairman and CEO of Debjon and Sidcor Group, and
as  Co-President  of MQM.  Mark has also served on the board of a joint  venture
between an emerging market government,  private enterprise,  and the World Bank.
He holds a B.B.A.  in  Economics  and  Marketing  from the  University  of South
Africa. Mark is a member of the Turnaround Management Association.

OUR SERVICES

Consulting Services

o    Financial

         As  financial   difficulties  are  frequently  the  most  urgent  issue
         confronting   companies  in  distress,   Getzler  Henrich's   financial
         consulting   services  are  focused  on  the   priorities  of  ensuring
         financing,  establishing  controls,  and  improving  overall  financial
         management. Specifically, Getzler Henrich will facilitate relationships
         with companies'  lending  institutions and investors;  help restructure
         company  debt and other  obligations;  assist with  valuations  and due
         diligence  if a sale or purchase  of a company or specific  division is
         required;  work to  optimize  cash flow and cash  management;  assemble
         projections of financial performance; and, monitor ongoing performance.

                                       2
<PAGE>

o    Operations

         Building  on  Getzler  Henrich's   successful   turnaround  and  crisis
         management track record, the firm has built deep operational consulting
         capabilities  to also help  healthy and  underperforming  organizations
         leverage  Lean  Manufacturing  and  Six  Sigma  techniques  to  achieve
         operational excellence.

         Our  methodology  focuses on  systematically  eliminating or minimizing
         waste,  maximizing productivity and efficiency from existing processes,
         people and  systems,  and  optimizing  manual  systems.  We do all this
         before   recommending  a  company  to  automate  or  make   substantial
         investments in technology  solutions...creativity  before capital. This
         means a company has a strategic roadmap before any capital  investments
         are even considered.

         Globally  our  executives  have  led  Six  Sigma  and  Lean  Management
         projects.  From the  assessment  phase  through  execution,  this group
         brings  a  distinct   hands-on   approach  to  drive   operational  and
         performance improvements.

                  o        Rapid Return on  Investment - with a tailored,  rapid
                           methodology, we bring a pragmatic approach to achieve
                           quick  gains  while  building a  longer-term  culture
                           focused on operational improvement.

                  o        Sustainable    Results   -   we    understand    that
                           sustainability  will only be  achieved  if  necessary
                           organizational  and process changes are facilitated -
                           not   dictated.   That  is  why  we  have  created  a
                           results-oriented, team-driven approach.

                  o        Effective  Implementation  - our approach begins with
                           an operational assessment that establishes a credible
                           fact-base  and  leads to a series  of  kaizen  events
                           focused  on areas  where  the  biggest  gains  can be
                           achieved.

         The operations  consulting services that Getzler Henrich provides focus
         on  managing a company's  operations  to  maximize  cash flow,  improve
         efficiency  and help  alleviate  the  strain on a  company's  financial
         situation.   Our  staff  is   experienced   in  strategic   operational
         improvement  by  focusing  on such  factors as  personnel  utilization,
         organizational  structure,  product  portfolios  and overhead.  We also
         devote particular  attention to improving  tactical  operational issues
         such as,  improving  service  performance,  responsiveness  to customer
         requirements/disputes,   company  position  with  respect  to  industry
         standards and requirements, and IT systems and reporting effectiveness.

o    Strategy

         Our  professionals  have extensive  experience  working with clients to
         develop and refine their corporate strategy by assessing their business
         units, the resources allocated to each and the competitive  dynamics of
         the marketplace.  We conduct a comprehensive  analysis to determine how
         to bolster high performers,  minimize the impact of underperformers (or

                                       3
<PAGE>

         those   misaligned   with  the  overall   strategy)   while   improving
         organizational structure to support these efforts.  Consistent with our
         straightforward  approach and focus on results, we work with executives
         to develop strategic plans with a clear path to improve  operations and
         increase shareholder value.

         Typically, our framework for strategic planning involves:

                  o        Mission &  Objectives  - we work with  leadership  to
                           articulate  the  company's  mission  that defines its
                           broader  purpose  and goals,  reflects  core  values,
                           galvanizes   employees   to   achieve   the   defined
                           objectives,  and  provides  a vision of  success  for
                           organization.

                  o        Market  Analysis - we examine the company's  internal
                           and  external  environments,  as it is and how it may
                           develop in the future.  The internal  analysis serves
                           to  identify  the  company's   unique  strengths  and
                           weaknesses   while  the  external   analysis  reveals
                           opportunities and threats.  The analysis will include
                           evaluation of pricing,  distribution  and  production
                           trends, as well as traditional  five-forces analysis:
                           entry  barriers,  suppliers,   customers,  substitute
                           products and major competitors.

                  o        Strategy  Formulation  - our  approach  combines  any
                           market  insights  gained with a rigorous  operational
                           assessment that establishes a credible  fact-base for
                           applying  its  strengths  to  opportunities  that are
                           identified  and  create  competitive   advantages  to
                           maximize  value.  In the  meantime,  the company must
                           address  any  significant   weaknesses  and  external
                           threats.

                  o        Strategy   Implementation   -  we   understand   that
                           sustainability  will only be  achieved  if  necessary
                           organizational  and process changes are facilitated -
                           not   dictated.   That  is  why  we  have  created  a
                           results-oriented,  team-driven  approach to implement
                           the defined  strategy  by  organizing  the  necessary
                           resources, leading the required programs, budgets and
                           initiatives,  and  achieving  the desired  results in
                           cooperation with leadership.

                  o        Evaluation & Control - our approach  insures that the
                           implementation   of  the   strategy  is   effectively
                           monitored and any adjustments made as needed. In this
                           way, we define which  parameters  are to be measured,
                           establish target values,  and provide for measurement
                           systems to monitor and get feedback from  implemented
                           processes to fully control the operation.

o    Sales and Marketing

          The sales and  marketing  consulting  services  that  Getzler  Henrich
          provides  focus on  assisting or managing a company to position it for
          growth,  improve  profitability,  and maximize cash flow. Our staff is
          experienced in enhancing sales and improving  marketing  effectiveness
          by  focusing on such  factors as  competitive  positioning,  strategic
          marketing   plan   development,   growth   opportunity   exploitation,

                                       4
<PAGE>

          control/expansion of margins, product/service offerings and life cycle
          management,  personnel utilization,  sales management,  organizational
          structure and overhead.

Management Services

o    Crisis Management

         Professionals  from Getzler  Henrich are often requested to function as
         corporate  management,  for a period,  during times of extreme  crisis.
         Getzler Henrich staff may assume senior management  functions until the
         crisis is successfully  managed or until  longer-term  management is in
         place.

o    Interim Management

          Getzler  Henrich  professionals  are sometimes  asked to serve as CEO,
          CFO, CRO, or COO of client  companies for a longer time period to help
          ensure the success of a turnaround situation.

Investment Banking Services

         Getzler Henrich  provides a broad range of investment  banking services
         including valuations,  refinancing (senior debt, mezzanine debt and new
         equity) and the purchase and sale of  companies,  divisions or specific
         assets.   Getzler   Henrich   has   excellent   research   and   target
         identification   capabilities  to  enhance  management's  knowledge  of
         potential  acquirers  or  targets.  Getzler  Henrich  also  has  strong
         relationships   with  relevant   financial   institutions   to  execute
         transactions in a timely and efficient fashion.

The terms of our agreement with you will be as follows:

SCOPE & TERMS OF ENGAGEMENT

Getzler Henrich shall, during the term of its engagement hereunder:

      o  For each of RC's subsidiaries as well as the consolidated organization:

         o  Review the business plan and underlying assumptions;

         o  Review  rolling  thirteen-week  cash flow model with  detailed  cash
            inflows and outflows as well as the underlying assumptions;

         o  Recommend operational and cash flow improvement alternatives;

         o  Determine and understand management's  performance  improvement/cost
            reduction plan and operating goals;

         o  Review inventory levels;

         o  Work in dealing with trade payables;

         o  Work with RC regarding  the sales process for Ronson  Avalon,  Inc.;
            and

                                       5
<PAGE>

         o  Assist RC and its subsidiaries in their negotiation with Wells Fargo
            Bank,  N.A., and its affiliates  (collectively,  "WF") in connection
            with the administration,  modification  and/or  restructuring of any
            and all credit arrangements with WF.

CONDITIONS OF ENGAGEMENT

RC agrees (i) to make  available to Getzler  Henrich all of RC's  financial  and
operational  information  and data as  requested  by Getzler  Henrich  (all such
information  so  furnished  being  the   "Information"),   and  (ii)  to  permit
discussions  with RC personnel,  in each case under  clauses (i) and (ii),  that
Getzler Henrich might reasonably require in connection with this engagement. All
such Information and discussions shall be subject to the terms and conditions of
the Confidentiality  Agreement which we have executed to RC. Notwithstanding the
foregoing, RC agrees that WF shall have unfettered access to Getzler Henrich and
Getzler  Henrich  shall  be free to  discuss  with and  disclose  to WF all such
Information and  discussions.  Getzler Henrich will keep RC generally  apprised,
and at the request of RC will keep it apprised, on the status of its discussions
with WF,  and will  provide  copies to RC of all  formal  and  detailed  written
reports  prepared by Getzler  Henrich and  delivered  to WF. RC  recognizes  and
confirms that Getzler Henrich (a) will use and rely primarily on the Information
and on  information  available  from  generally  recognized  public  sources  in
performing  the  services   contemplated  hereby  without  having  independently
verified any of the same and (b) does not assume responsibility for accurateness
or completeness  of the Information and such other  information and (c) will not
make an appraisal of any of the assets or liabilities of RC.

FEES

All work  performed  will be billed on an hourly basis.  Our hourly rates are as
follows:

          Principal / Managing Director                  $405-550
          Vice President / Director                      $335-485
          Associate Professionals and Consultants        $190-375

Hourly rates are revised periodically. We will notify you of any such changes to
our rates.  Note that we do not provide  assurance  regarding the outcome of our
work and our fees will not be contingent on the results of such work.

Getzler  Henrich  will  bill RC  weekly  for fees and  reasonable  out-of-pocket
expenses  incurred by Getzler Henrich in connection  with the services  rendered
herein.  Such  expenses  include,  but are not  limited to,  out-of-town  travel
(meals,  lodging,  parking,  etc.),  telephone  calls,  general office services,
delivery  services,  and photocopying.  All out-of-pocket  expenses in excess of
Five  Hundred  Dollars  ($500) per week are subject to prior  approval by RC. RC
acknowledges  that Getzler Henrich invoices are due and payable each week within
three (3) business days of  presentation.  If an invoice is not paid on a timely
basis, we reserve the right to cease work until the matter is settled.

To the  extent  that any  services  outside  the  scope of this  engagement  are
required  or  requested,  the  extent  of  these  services,  and the  additional
compensation  to be paid to Getzler  Henrich for such services,  shall be agreed
upon prior to Getzler Henrich beginning to perform such services. These services
will be entered into under a separate engagement letter.

                                       6
<PAGE>

A retainer of $25,000  will be  required  and will be applied to the final bill.
Any  unearned  portion  will  be  refunded  promptly  upon  termination  of this
engagement.

Except for the  services to be provided by Getzler  Henrich,  during the term of
this  engagement  and for a  period  of two  (2)  years  thereafter,  RC and its
subsidiaries shall not utilize,  whether as employee or independent  consultant,
and whether directly, or indirectly,  the services of any person who is, was, or
had been employed by Getzler Henrich during the term of this engagement and with
whom RC or its subsidiaries comes into contact.

RC will indemnify,  defend and hold harmless  Getzler Henrich and its affiliates
and their respective shareholders,  directors,  officers, employees, and agents,
(each an "Indemnified Party"),  from and against any and all claims,  liability,
loss, cost, damage, or expense (including  reasonable  attorneys' fees) asserted
against or incurred by any indemnified Party, by reason of, or arising out of or
in connection with, this agreement or performance under this agreement,  whether
such claim,  liability,  loss, cost, damage, or expense is asserted by RC or any
other  person  or  entity,  except  in a case of  gross  negligence  or  willful
misconduct by an Indemnified Party.

No  Indemnified  Party  may  settle or  compromise  or  consent  to the entry of
judgment in any pending or threatened  action without the prior written  consent
of RC. In the event of the assertion  against any Indemnified Party of any claim
or the  commencement  of any  action  or  proceeding,  RC shall be  entitled  to
participate  in such  action or  proceeding,  and in the  investigation  of such
claim,  and after written notice from RC to assume the  investigation or defense
of such claim, action or proceeding with counsel reasonably  satisfactory to the
Indemnified  Party unless such Indemnified  Party is advised by its counsel that
such representation  would be a conflict or that there are defenses available to
the Indemnified Party which are not available to RC.

If Getzler  Henrich is requested or required to appear and/or testify before any
tribunal by RC,  whether or not pursuant to lawful  process,  all time spent and
reasonable out-of-pocket  expenditures by Getzler Henrich,  including reasonable
fees for legal  counsel,  shall be considered to have been  performed  under the
terms of this  engagement,  and  Getzler  Henrich  shall be  entitled to receive
payment of fees and reimbursement of expenses therefore.

Either RC or Getzler  Henrich can terminate this agreement upon one week's prior
written notice, except for the indemnification  paragraph and payment provisions
above, and the provisions of our Confidentiality  Agreement, which shall survive
any termination.  Outstanding  amounts due Getzler Henrich, if any, will be paid
promptly upon receipt of a final invoice that will be provided  immediately upon
notice of termination by RC.

This Engagement  Letter,  and the  Confidentiality  Agreement executed by RC and
Getzler Henrich  contains the entire agreement among the parties relating to the
subject  herein except.  Any  modification  or other changes to this  Engagement

                                       7
<PAGE>

Letter must be in writing and signed by the parties hereto to be enforceable.

Please  confirm  your  acceptance  of the terms of our  agreement by signing and
returning one copy of this letter.

The retainer  should be wired to Getzler  Henrich & Associates LLC c/o JP Morgan
Chase Bank,  account # 621505952665,  routing/ABA # 021 0000 21. Future payments
should be wired to that account as well.

                                       8
<PAGE>

We look  forward to  working  with you.  Please  feel free to contact me for any
additional information or clarification.

Sincerely,

s/JOEL GETZLER
--------------------------------------------
Joel Getzler
Vice Chairman

Ronson Corporation
Agreed to and Accepted:

By:          s/LOUIS V. ARONSON II
             -------------------------------

Print Name:  Louis V. Aronson II
             -------------------------------

Title:       President and C.E.O.
             -------------------------------

Date:        January 12, 2009
             -------------------------------

                                       9c57143_ex10-1.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.1

SUBSCRIPTION AGREEMENT

Savient Pharmaceuticals, Inc. 

One Tower Center 

14th Floor 

East Brunswick, New Jersey 08816

Gentlemen: 

     The undersigned (the “Investor”) hereby confirms its agreement with Savient Pharmaceuticals, Inc., a Delaware corporation (the
“Company”), as follows: 

     1. This Subscription Agreement, including the Terms and Conditions for Purchase of Units attached hereto as Annex I (collectively, this “Agreement”) is made as of the date set forth below between the Company and the Investor. 

     2. The Company has authorized the sale and issuance to certain investors of up to an aggregate of 5,927,343 units (the
“Units”), subject to adjustment by the Company’s Board of Directors or a committee thereof, with each Unit consisting of (i) one share (the “Share,” collectively,
the “Shares”) of its common stock, par value $0.01 per share (the “Common Stock”), and (ii) one warrant (the “Warrant,” collectively, the “Warrants”) to purchase 0.85 shares of Common Stock (and the fractional amount being the
“Warrant Ratio”), in substantially the form attached hereto as Exhibit B, for a purchase price of $5.23 per Unit (the
“Purchase Price”). Units will not be issued or certificated. The Shares and Warrants are immediately separable and will be issued separately. The shares of Common Stock issuable
upon exercise of the Warrants are referred to herein as the “Warrant Shares” and, together with the Units, the Shares and the Warrants, are referred to herein as the
“Securities”). 

     3. The offering and sale of the Units (the “Offering”) are
being made pursuant to (a) an effective Registration Statement on Form S-3, No. 333-146257 (the “Registration Statement”) filed by the Company with the Securities and Exchange
Commission (the “Commission”), including the Prospectus contained therein (the “Base Prospectus”), (b) if
applicable, certain “free writing prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended (the “Act”)), that have been or will be
filed, if required, with the Commission and delivered to the Investor on or prior to the date hereof (the “Issuer Free Writing Prospectus”), containing certain supplemental
information regarding the Units, the terms of the Offering and the Company and (c) a Prospectus Supplement (the “Prospectus
Supplement” and, together with the Base Prospectus, the “Prospectus”) containing certain supplemental information regarding the Units and terms
of the Offering that will be filed with the Commission and delivered to the Investor (or made available to the Investor by the filing by the Company of an electronic version thereof with the Commission). 

     4. The Company and the Investor agree that the Investor will purchase from the Company and the Company will issue and sell to the
Investor the Units set forth below for the aggregate purchase price set forth below. The Units shall be purchased pursuant to the Terms and Conditions for Purchase of Units attached hereto as Annex I and incorporated herein by this reference as if fully set forth herein. The Investor acknowledges that the Offering is not being underwritten by the placement agent (the “Placement
Agent”) named in the Prospectus Supplement and that there is no minimum offering amount. 

     5. The manner of settlement of the Shares included in the Units purchased by the Investor shall be determined by such Investor as
follows (check one): 

 

	[____] 	A. 	Delivery by crediting the account of the Investor's
        prime broker (as specified by such Investor on Exhibit
        A annexed hereto) with the Depository Trust
        Company (“DTC”)
        through its Deposit/Withdrawal At Custodian ("DWAC")
        system, whereby Investor's prime broker shall initiate a DWAC transaction
        on the Closing Date using its DTC participant identification number,
        and released by American Stock Transfer & Trust Co., the Company’s
        transfer agent (the “Transfer Agent”),
        at the Company's direction. NO LATER
        THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE
    INVESTOR AND THE COMPANY, THE INVESTOR SHALL: 
	 	 	 	 
	 	 	(I) 	DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR
          ACCOUNTS TO BE CREDITED WITH THE SHARES ARE MAINTAINED TO SET
          UP A DWAC INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR
    ACCOUNTS WITH THE SHARES, AND 
	 	 	 	 
	 	 	(II)	REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL
          TO THE AGGREGATE PURCHASE PRICE FOR THE UNITS BEING PURCHASED BY THE
    INVESTOR TO THE FOLLOWING ACCOUNT: 
	 	 	 	 
	 	 	JPMorgan Chase Bank, N.A. 

ABA # 021000021

Account Name: Savient Pharmaceuticals, Inc. 

Account Number: 806021036 

Attention: Audrey
Cohen 

Tel: (212) 623-5078 
	 	 	 	 
	 	– OR – 
	 	 	 	 
	[____] 	B. 	Delivery versus payment
        (“DVP”)
        through DTC (i.e.,
        on the Closing Date, the Company shall deliver the Shares registered
        in the Investor’s name and address as set forth below and released
        by the Transfer Agent to the Investor through DTC at the Closing directly
        to the account(s) at Lazard Capital Markets LLC (“LCM”)
        identified by the Investor; upon receipt of such Shares, LCM shall promptly
        electronically deliver such Shares to the Investor, and simultaneously
        therewith payment shall be made by LCM by wire transfer to the
        Company). NO LATER THAN ONE (1) BUSINESS
        DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY,
    THE INVESTOR SHALL:
	 	 	 	 
	 	 	(I)	 NOTIFY LCM OF THE ACCOUNT OR ACCOUNTS
          AT LCM TO BE CREDITED WITH THE SHARES BEING PURCHASED BY SUCH INVESTOR,
    AND
	 	 	 	 
	 	 	 	 

- 2 - 

 

 

	 	 	(II)	CONFIRM THAT THE ACCOUNT OR ACCOUNTS
          AT LCM TO BE CREDITED WITH THE SHARES BEING PURCHASED BY THE INVESTOR HAVE
          A MINIMUM BALANCE EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE UNITS
    BEING PURCHASED BY THE INVESTOR.

IT IS THE INVESTOR’S RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT BY WAY OF DWAC OR DVP IN A TIMELY MANNER.  IF THE
INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE UNITS OR DOES NOT MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER, THE SHARES AND WARRANTS MAY NOT BE DELIVERED AT CLOSING TO THE INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM
THE CLOSING ALTOGETHER, AT THE COMPANY’S DISCRETION. 

6. The executed Warrant shall be delivered in accordance with the terms thereof. 

7. The Investor represents that, except as set forth below, (a) it has had no position, office or other material relationship within the past three years with the Company or persons known to it to be affiliates of the Company, (b)
it is not a member of the Financial Industry Regulatory Authority, Inc. or an Associated Person (as such term is defined under the NASD Membership and Registration Rules Section 1011) as of the Closing, and (c) neither the Investor nor any group of
Investors (as identified in a public filing made with the Commission) of which the Investor is a part in connection with the Offering of the Units, acquired, or obtained the right to acquire, 20% or more of the Common Stock (or securities
convertible into or exercisable for Common Stock) or the voting power of the Company on a post-transaction basis. Exceptions: 

(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”) 

8. The Investor represents that it has received (or otherwise had made available to it by the filing by the Company of an electronic version thereof with the Commission) the Base Prospectus which
is a part of the Company’s Registration Statement, the documents incorporated by reference therein and any free writing prospectus (collectively, the “Disclosure Package”),
prior to or in connection with the receipt of this Agreement. The Investor acknowledges that, prior to the delivery of this Agreement to the Company, the Investor will receive certain additional information regarding the Offering, including pricing
information (the “Offering Information”). Such information may be provided to the Investor by any means permitted under the Act, including the Prospectus Supplement, a free writing
prospectus and oral communications. 

9. No offer by the Investor to buy Units will be accepted and no part of the Purchase Price will be delivered to the Company until the Investor has received the Offering Information and the Company
has accepted such offer by countersigning a copy of this Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to the Company (or Placement Agent on behalf of the Company) sending
(orally, in writing or by electronic mail) notice of its acceptance of such offer. An indication of interest will involve no obligation or commitment of any kind until the Investor has been delivered the Offering Information and this Agreement is
accepted and countersigned by or on behalf of the Company. The Investor understands and agrees that the Company, in its sole discretion, reserves the right to accept or reject this subscription for Units, in whole or in part. 

- 3 -

10. The Company acknowledges that the only material, non-public information relating to the Company it has provided to the Investor in connection with the Offering prior to the date hereof is the
existence of the Offering. 

11. For so long as any Warrants remain outstanding, the Company shall not, in any manner, issue or sell any rights, warrants or options to subscribe for or purchase Common Stock, or directly or
indirectly convertible into or exchangeable for Common Stock at a price which resets as a function of market price of the Common Stock, unless the conversion, exchange or exercise price of any such security cannot be less than the then applicable
Exercise Price (as defined in the Warrants) with respect to the Common Stock into which any Warrant is exercisable. 

- 4 -

Number of Units:                                                                             

Purchase Price Per Unit: $                                                                

Aggregate Purchase Price: $                                                            

     
 Please confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose. 

 

	 	 	Dated as of: April 2, 2009	 
	 	 	 	 
	 	 	 	 
	 	 	INVESTOR	 
	 	 	 	 
	 	 	By:                                                                      

      Print Name:                                                         

      Title:                                                                    

      Address:                                                              

                                                                            

                                                                                       	 

 

Agreed and Accepted 

  this 2nd day of April, 2009:

SAVIENT PHARMACEUTICALS, INC.

By:                                                             

Title:

- 5 -

ANNEX I 

TERMS AND CONDITIONS FOR PURCHASE OF UNITS 

     1. Authorization and Sale of the Units.  Subject to the terms and conditions of this Agreement, the Company has authorized the sale of the Units. 

     
2. Agreement to Sell and Purchase the Units; Placement Agent. 

          2.1 At the Closing (as defined in Section 3.1), the Company will sell to the Investor, and the Investor will
purchase from the Company, upon the terms and conditions set forth herein, the number of Units set forth on the last page of the Agreement to which these Terms and Conditions for Purchase of
Units are attached as Annex I (the “Signature Page”) for the
aggregate purchase price therefor set forth on the Signature Page. 

          2.2 The Company proposes to enter into substantially this same form of Subscription Agreement with certain other investors (the “Other Investors”) and expects to complete sales of Units to them. The Investor and the Other Investors are hereinafter sometimes collectively referred to as the
“Investors,” and this Agreement and the Subscription Agreements executed by the Other Investors are hereinafter sometimes collectively referred to as the “Agreements.”

          2.3 Investor acknowledges that the Company has agreed to pay Lazard Capital Markets LLC (the “Placement Agent” or “LCM”) a fee (the “Placement Fee”) in respect of the sale of Units to the Investor.

          2.4 The Company has entered into a Placement Agent Agreement, dated April 2, 2009 (the “Placement Agreement”), with the Placement Agent that contains certain representations, warranties, covenants and agreements of the Company that may be relied upon by the Investor, which shall be a third party beneficiary thereof. 

3. Closing and Delivery of the Shares, Warrants and Funds. 

          3.1 Closing. The completion of the purchase and sale of the Units (the “Closing”) shall occur at a place and time (the “Closing Date”) to be specified by the Company and the Placement Agent, and of which
the Investors will be notified in advance by the Placement Agent, in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). At the Closing, (a) the Company shall cause the Transfer Agent to deliver to the Investor the number of Shares set forth on the Signature Page registered in the name of the Investor or, if so indicated on the Investor
Questionnaire attached hereto as Exhibit A, in the name of a nominee designated by the Investor, (b) the Company shall cause to be delivered to the Investor a Warrant to purchase a number of
whole Warrant Shares determined by multiplying the number of Shares set forth on the signature page by the Warrant Ratio and rounding down to the nearest whole number and (c) the aggregate purchase price for the Units being purchased by the Investor
will be delivered by or on behalf of the Investor to the Company.

- 6 -

          
3.2 Conditions to the Obligations of the Parties.

                (a) Conditions to the Company’s Obligations. The Company’s obligation to issue and sell
the Units to the Investor shall be subject to: (i) the receipt by the Company of the purchase price for the Units being purchased hereunder as set forth on the Signature Page and (ii) the accuracy of the representations and warranties made by the
Investor and the fulfillment of those undertakings of the Investor to be fulfilled prior to the Closing Date. 

               (b) Conditions to the Investor’s Obligations. The Investor’s obligation to purchase the
Units will be subject to the accuracy of the representations and warranties made by the Company and the fulfillment of those undertakings of the Company to be fulfilled prior to the Closing Date, including without limitation, those contained in the
Placement Agreement, and to the condition that the Placement Agent shall not have: (i) terminated the Placement Agreement pursuant to the terms thereof or (ii) determined that the conditions to the closing in the Placement Agreement have not been
satisfied. The Investor’s obligations are expressly not conditioned on the purchase by any or all of the Other Investors of the Units that they have agreed to purchase from the Company.  The Investor understands and agrees that, in the event
that the Placement Agent in its sole discretion determines that the conditions to closing in the Placement Agreement have not been satisfied or if the Placement Agent Agreement may be terminated for any other reason permitted by such Agreement, then
the Placement Agent may, but shall not be obligated to, terminate such Agreement, which shall have the effect of terminating this Subscription Agreement pursuant to Section 14 below. 

          
3.3 Delivery of Funds.

               (a) DWAC Delivery. If the Investor elects to settle the Shares purchased by such Investor through DTC’s Deposit/Withdrawal at Custodian
(“DWAC”) delivery system, no later than one (1) business day after the
execution of this Agreement by the Investor and the Company, the Investor shall remit by wire transfer the amount of funds equal to the
aggregate purchase price for the Units being purchased by the Investor to the following account designated by the Company and the Placement Agent pursuant to the terms of that certain Escrow Agreement (the “Escrow
Agreement”) dated as of the date hereof, by and among the Company, the Placement Agent and JPMorgan Chase Bank, N.A. (the “Escrow Agent”):

JPMorgan Chase Bank, N.A. 

ABA # 021000021

Account Name: Savient Pharmaceuticals,
Inc. 

Account Number: 806021036 

Attention:
Audrey Cohen 

Tel: (212) 623-5078 

     Such funds shall be held in escrow until the Closing and delivered by the Escrow Agent on behalf of the Investors to the Company upon the satisfaction, in the sole judgment of the Placement Agent, of
the conditions set forth in Section 3.2(b) hereof. The Placement Agent shall have no rights in or to any of the escrowed funds, unless the Placement Agent and the Escrow Agent are notified in writing by the Company in connection with the Closing
that a portion of the escrowed funds shall be applied to the Placement Fee. The Company agrees to indemnify and hold the Escrow Agent harmless from and against any and all losses, costs, damages, expenses and claims (including, 

- 7 -

without limitation, court costs and reasonable attorneys fees) (“Losses”) arising under this Section 3.3 or otherwise with respect to the funds held in escrow pursuant hereto or arising under the Escrow Agreement, except to the extent that it is finally, judicially determined that such Losses resulted from the willful misconduct or gross
negligence of the Escrow Agent. Anything in this Agreement to the contrary notwithstanding, in no event shall the Escrow Agent be liable for any special, indirect or consequential loss or damage of any kind whatsoever (including but not limited to
lost profits), even if the Escrow Agent has been advised of the likelihood of such loss or damage and regardless of the form of action. 

               (b) Delivery Versus Payment through The Depository Trust Company.  If the Investor elects to settle the Shares purchased by such Investor by
delivery versus payment through DTC, no later than one (1) business day after the execution of this Agreement by the Investor and the
Company, the Investor shall confirm that the account or accounts at the Placement Agent to be credited with the Units being purchased by the Investor have a minimum balance equal to the aggregate purchase price for
the Units being purchased by the Investor.

          
3.4 Delivery of Shares.

               (a) DWAC Delivery. If the Investor elects to settle the Shares purchased by such Investor through DTC’s DWAC delivery system,
no later than one (1) business day after the execution of this Agreement by the Investor and the Company, the
Investor shall direct the broker-dealer at which the account or accounts to be credited with the Shares being purchased by such Investor are maintained, which broker/dealer shall be a DTC participant, to set up a DWAC instructing American Stock
Transfer & Trust Co., the Company’s “Transfer Agent”, to credit such account or accounts with the Shares. Such DWAC instruction shall indicate the settlement date for the
deposit of the Shares, which date shall be provided to the Investor by LCM. Simultaneously with the delivery to the Company by the Escrow Agent of the funds held in escrow pursuant to Section 3.3 above, the Company shall direct the Transfer Agent to credit the Investor’s account or accounts with the Shares pursuant to the information contained in the DWAC.

               (b) Delivery Versus Payment through The Depository Trust Company.  If the Investor elects to settle the Shares purchased by such Investor by
delivery versus payment through DTC, no later than one (1) business day after the execution of this Agreement by the Investor and the
Company, the Investor shall notify LCM of the account or accounts at LCM to be credited with the Shares being purchased by such Investor.  On the Closing Date, the Company shall deliver the Shares to the Investor
through DTC directly to the account(s) at LCM identified by Investor and simultaneously therewith payment shall be made by LCM by wire transfer to the Company.

     
4. Representations, Warranties and Covenants of the Investor. 

     
 The Investor acknowledges, represents and warrants to, and agrees with, the Company and the Placement Agent that: 

          4.1 The Investor (a) is knowledgeable, sophisticated and experienced in making, and is qualified to make decisions with respect to, investments in shares presenting an
investment decision like that involved in the purchase of the Units, including investments in securities issued by the Company and investments in comparable companies, (b) has answered all questions on the Signature Page and the Investor
Questionnaire and the answers thereto are true and correct as of the date hereof and will be true and correct as of the Closing Date and (c) in connection with its decision to purchase 

- 8 - 

the number of Units set forth on the Signature Page, has received and is relying only upon the Disclosure Package and the documents incorporated by reference therein and the Offering Information.

          4.2 (a) No action has been or will be taken in any jurisdiction outside the United States by the Company or the Placement Agent that would permit an offering of the
Units, or possession or distribution of offering materials in connection with the issue of the Securities in any jurisdiction outside the United States where action for that purpose is required, (b) if the Investor is outside the United States, it
will comply with all applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its possession or distributes any offering material, in all cases at its own expense and (c) the
Placement Agent is not authorized to make and has not made any representation, disclosure or use of any information in connection with the issue, placement, purchase and sale of the Units, except as set forth or incorporated by reference in the Base
Prospectus or the Prospectus Supplement or any free writing prospectus. 

          4.3 (a) The Investor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken
all necessary action to authorize the execution, delivery and performance of this Agreement, and (b) this Agreement constitutes a valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms, except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles
of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and except as to the enforceability of any rights to indemnification or contribution that may be violative of the public policy underlying any
law, rule or regulation (including any federal or state securities law, rule or regulation). 

          4.4 The Investor understands that nothing in this Agreement, the Prospectus, the Disclosure Package, the Offering Information or any other materials presented to the
Investor in connection with the purchase and sale of the Units constitutes legal, tax or investment advice.  The Investor has consulted such legal, tax and investment advisors and made such
investigation as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Units. The Investor also understands that there is no established public trading market for the Warrants being offered in the
Offering, and that the Company does not expect such a market to develop. In addition, the Company does not intend to apply for listing the Warrants on any securities exchange. Without an active market, the liquidity of the Warrants will be limited.

          4.5 Since the date on which the Placement Agent first contacted the Investor about the Offering, the Investor has not disclosed any information regarding the Offering
to any third parties (other than its legal, accounting and other advisors) and has not engaged in any purchases or sales involving the securities of the Company (including, without limitation, any Short Sales involving the Company’s
securities).  The Investor covenants that it will not engage in any purchases or sales involving the securities of the Company (including Short Sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed. The
Investor agrees that it will not use any of the Securities acquired pursuant to this Agreement to cover any short position in the Common Stock if doing so would be in violation of applicable securities laws.  For purposes hereof,
“Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the
box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as

- 9 -

defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers. 

     5. Survival of Representations, Warranties and Agreements; Third Party Beneficiary.  Notwithstanding any investigation made by any party to this Agreement or by the
Placement Agent, all covenants, agreements, representations and warranties made by the Company and the Investor herein will survive the execution of this Agreement, the delivery to the Investor of the Shares and Warrants being purchased and the
payment therefor.  The Placement Agent and Lazard Fréres & Co. shall be third party beneficiaries with respect to the representations, warranties and agreements of the Investor in Section 4 hereof. 

     6. Notices. All notices, requests, consents and other communications hereunder will be in writing, will be mailed (a) if within the domestic United States by
first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered from outside the United States, by International Federal Express or facsimile, and (c) will be
deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by
International Federal Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic confirmation of receipt and will be delivered and addressed as follows: 

	 	(a)	if to the Company, to:
	 	 	 
	 	 	Savient Pharmaceuticals, Inc. 

      One Tower Center 

      14th Floor East Brunswick, New Jersey 08816 

      Attention: Philip K. Yachmetz, Esq. 

      Facsimile: (732) 418-0570 

       with copies to:

       Wilmer Cutler Pickering Hale and Dorr
          LLP 

        60 State Street 

        Boston, Massachusetts 02109 

        Attention: Graham Robinson, Esq. 

    Facsimile: (617) 526-5000 

	 	 	 
	                                                                        	(b)	 if
        to the Investor, at its address on the Signature Page hereto, or at such
        other address or addresses as may have been furnished to the Company
    in writing. 

7. Changes.  This Agreement may not be modified or amended except pursuant to an instrument in writing signed by the Company and the Investor. 

8. Headings. The headings of the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement. 

- 10 -

9. Severability.  In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions
contained herein will not in any way be affected or impaired thereby. 

10. Governing Law. This Agreement will be governed by, and construed in accordance with, the internal laws of the State of New York, without giving effect to the principles of conflicts of law that
would require the application of the laws of any other jurisdiction. 

11. Counterparts. This Agreement may be executed in two or more counterparts, each of which will constitute an original, but all of which, when taken together, will constitute but one instrument,
and will become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties. The Company and the Investor acknowledge and agree that the Company shall deliver its counterpart to the Investor along
with the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission).

12. Confirmation of Sale.  The Investor acknowledges and agrees that such Investor’s receipt of the Company’s signed counterpart to this Agreement, together with the Prospectus Supplement
(or the filing by the Company of an electronic version thereof with the Commission), shall constitute written confirmation of the Company’s sale of the Units to such Investor. 

13. Press Release. The Company and the Investor agree that the Company shall, prior to the opening of the financial markets in New York City on the business day immediately after the date hereof,
(a) issue a press release announcing the Offering and disclosing all material information regarding the Offering and (b) file a Current Report on Form 8-K with the Securities and Exchange Commission including a form of this Agreement and a form of
Warrant as exhibits thereto. 

14. Termination.  In the event that the Placement Agreement is terminated by the Placement Agent pursuant to the terms thereof, this Agreement shall terminate without any further action on the part
of the parties hereto. 

- 11 -

  

	 	EXHIBIT A
	 

SAVIENT PHARMACEUTICALS, INC.

  

  INVESTOR QUESTIONNAIRE 

     Pursuant to Section 3 of Annex I to the Agreement, please provide us with the
following information: 

	
1.   	   	
The exact name that your Shares and Warrants   	 
	   	   	
are to be registered in. You may use a nominee   
	   	   	
name if appropriate:   
	   
	
2.   	   	
The relationship between the Investor and the   	 
	   	   	
registered holder listed in response to item 1   
	   	   	
above:   
	   
	
3.   	   	
The mailing address of the registered holder   	 
	   	   	
listed in response to item 1 above:   
	   
	
4.   	   	
The Social Security Number or Tax   	 
	   	   	
Identification Number of the registered holder   
	 	 	listed in the response to item 1 above: 	 
	   
	
5.   	   	
Name of DTC Participant (broker-dealer at   	 
	   	   	
which the account or accounts to be credited   
	   	   	
with the Shares are maintained):   
	   
	
6.   	   	
DTC Participant Number:   	 
	   
	
7.   	   	
Name of Account at DTC Participant being   	 
	   	   	
credited with the Shares:   
	   
	
8.   	   	
Account Number at DTC Participant being   	 
	   	   	
credited with the Shares:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]